The maker of surgical robots is grappling with concerns about competition.
SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that ...
2026 hasn't been a happy New Year so far for Intuitive Surgical (NASDAQ: ISRG) shareholders. The robotic surgical systems stock is in negative territory. And Intuitive's latest quarterly results ...
Intuitive Surgical stock jumped Wednesday after the robotic surgery giant easily beat first-quarter sales and earnings calls.
Intuitive Surgical's share price has rebounded after a sharp drop, driven by strong Q1 2025 results and easing tariff concerns, with further upside expected. As the dominant leader in robotic surgery, ...
Intuitive Surgical’s ISRG third-quarter performance highlights a pivotal shift in its platform mix, with robotic bronchoscopy, formerly a peripheral initiative, rapidly emerging as a core growth ...
SYRACUSE, N.Y. — Crouse Health has a new tool to help you detect and treat lung cancer earlier and in a less invasive way. The Ion Robotic System from Intuitive allows for a minimally invasive biopsy ...
THOMASVILLE — Archbold Pulmonology offers patients state-of-the-art technology with the Intuitive Ion robotic bronchoscopy system—a cutting-edge platform that enables pulmonologists to reach ...
On April 23, 2026, Barclays lowered its price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $651 from $712 while ...
Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...